Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1994;43:143–201.
Matucci CM, McCarthy G, Lombardi A, Pignone A, Partsch G. Neurogenic influences in arthritis: potential modification by capsaicin. J Rheumatol 1995;22:1447–9.
Sicuteri F, Fusco BM, Marabini S, et al. Beneficial effect of capsaicin application to the nasal mucosa in cluster headache. Clin J Pain 1989;5:49–53.
Watson CP, Evans RJ, Watt VR. Post-herpetic neuralgia and topical capsaicin. Pain 1988;33:333–40.
Marabini S, Ciabatti G, Polli G, Fusco BM, Geppetti P. Beneficial effect of intranasal applications of capsaicin in patients with vasomotor rhinitis. Eur Arch Otorhino- laryngol 1991;248:191–4.
Kang SN, Chung SW, Kim TS. Capsaicin potentiates 1,25-dihydoxyvitamin D3- and ATRA-induced differen- tiation of human promyelocytic leukemia HL-60 cells. Eur J Pharmacol 2001;420:83–90.
Zhang J, Nagasaki M, Tanaka Y, Morikawa S. Capsaicin inhibits growth of adult T-cell leukemia cells. Leuk Res 2003;27:275–83.
Ito K, Nakazato T, Yamato K, et al. Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: Implica- tion of phosphorylation of p53 at ser-15 residue by reactive oxygen species. Cancer Res 2004;64:1071–8.
Kim JD, Kim JM, Pyo JO, et al. Capsaicin can alter the expression of tumor forming-related genes which might be followed by induction of apoptosis of a Korean stomach cancer cell line, SNU-1. Cancer Lett 1997;120: 235–41.
Jung MY, Kang HJ, Moon A. Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 down-regulation and caspase-3 activation. Cancer Lett 2001;165:139–45.
Pang S, Dannull J, Kaboo R, et al. Identification of a positive regulatory element responsible for tissue- specific expression of prostate-specific antigen. Cancer Res 1997;57:495–9.
Schuur ER, Henderson GA, Kmetec LA, Miller JD, Lamparski HG, Henderson DR. PSA expression is regulated by an upstream enhancer. J Biol Chem 1996; 271:7043–51.
Capsaicin Inhibits the Growth of Prostate Cancer Cells
Palayoor ST, Youmell MY, Calderwood SK, Coleman CN, Prince BD. Constitutive activation of InB kinase a and NF-nB in prostate cancer cells is inhibited by ibuprofen. Oncogene 1999;18:7389–94.
Karin M, Ben-Neriar Y. Phosphorylation meets ubiquitination: the control of NF-nB activity. Annu Rev Immunol 2000;18:621–63.
Baeuerle PA, Baltimore D. NF-nB: ten years after. Cell 1996;87:13–20.
Miyamoto S, Verma IM. Rel/NF-nB/InB story. Adv Cancer Res 1995;66:255–92.
Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA. Phosphorylation of human InB-a on serines 32 and 36 controls InB-a proteolysis and NF-nB activation in response to diverse stimuli. EMBO J 1995;14:2876–83.
Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS. NF-nB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase- 8 activation. Science 1998;281:1680–3.
Singh S, Natarajan K, Aggarwal BB. Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibi- tor of nuclear transcription factor-nB activation by diverse agents. J Immunol 1996;157:4412–20.
Kumagai T, O’Kelly J, Said JW, Koeffler HP. Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells. J Natl Cancer Inst 2003;95:896–905.
Hisatake JI, Ikezoe T, Carey M, Holden S, Tomoyasu S, Koeffler HP. Down-regulation of prostate-specific anti- gen expression by ligands for peroxisome proliferator- activated receptor g in human prostate cancer. Cancer Res 2000;60:5494–8.
Pajonk F, Riess K, Sommer A, McBride WH. N-Acetyl- L-cysteine inhibits 26S proteasome function: implica- tions for effects on NF-nB activation. Free Radic Biol Med 2002;32:536–43.
Huang W, Shostak Y, Tarr P, Sawyers C, Carey M. Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate- specific antigen enhancer. J Biol Chem 1999;274:25756–68.
Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 1999;51: 159–212.
Lin HK, Altuwaijri S, Lin WJ, Kan PY, Collins LL, Chang C. Proteasome activity is required for androgen
receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J Biol Chem 2002;27:36570–6.
Sovak MA, Bellas RE, Kim DW, et al. Aberrant nuclear factor-nB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 1997;100:2952–60.
Pajonk F, Pajonk K, McBride WH. Apoptosis and radiosensitization of Hodgkin cells by proteasome inhibition. Int J Radiat Oncol Biol Phys 2000;47: 1025–32.
Lin HK, Wang L, Hu C, Altuwaijri S, Chang C. Phosphorylation-dependent ubiquitylation and degra- dation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J 2002;21:4037–48.
Poukka H, Karvonen U, Yoshikawa N, Tanaka H, Palvimo JJ, Janne OA. The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor. J Cell Sci 2000;113:2991–3001.
Yeh S, Hu YC, Rahman M, et al. Increase of androgen- induced cell death and androgen receptor transactiva- tion by BRCA1 in prostate cancer cells. Proc Natl Acad Sci U S A 2000;97:11256–61.
Kang HY, Yeh S, Fujimoto N, Chang C. Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. J Biol Chem 1999;274:8570–6.
Szolcsa´nyi J. Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides 2004;38:377–84.
Raisinghani M, Pabbidi RB, Premkumar LS. Activa- tion of transient receptor potential vanilloid 1 (TRPV1) by resiniferatoxin. J Physiol 2005;567:771–86.
Qiao S, Li W, Tsubouchi R, Haneda M, Murakami K, Yoshino M. Involvement of peroxynitrite in capsaicin- induced apoptosis of C6 glioma cells. Neurosci Res 2005; 51:175–83.
Wolvetang EJ, Larm JA, Moutsoulas P, Lawen A. Apoptosis induced by inhibitors of the plasma mem- brane NADH-oxidase involves Bcl-2 and calcineurin. Cell Growth Differ 1996;7:1315–25.
Park JY, Kawada T, Han IS, et al. Capsaicin inhibits the production of tumor necrosis factor a by LPS- stimulated murine macrophages, RAW 264.7: a PPARg ligand-like action as a novel mechanism. FEBS Lett 2004;572:266–70.
Cancer Res 2006; 66: (6). March 15, 2006